HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H2S inhibition of chemical hypoxia-induced proliferation of HPASMCs is mediated by the upregulation of COX-2/PGI2.

Abstract
The hypoxia-induced proliferation of pulmonary artery smooth muscle cells (PASMCs) is the main cause of pulmonary arterial hypertension (PAH), in which oxidative stress, cyclooxygenase (COX)-2 and hydrogen sulfide (H(2)S) all play an important role. In the present study, we aimed to examine the effects of H(2)S on the hypoxia-induced proliferation of human PASMCs (HPASMCs) and to elucidate the underlying mechanisms. The HPASMCs were treated with cobalt chloride (CoCl(2)), a hypoxia-mimicking agent, to establish a cellular model of hypoxic PAH. Prior to treatment with CoCl(2), the cells were pre-conditioned with sodium hydrosulfide (NaHS), a donor of H(2)S. Cell proliferation, reactive oxygen species (ROS) production, COX-2 expression, prostacyclin (also known as prostaglandin I2 or PGI(2)) secretion and H(2)S levels were detected in the cells. The exposure of the HPASMCs to CoCl(2) markedly increased cell proliferation, accompanied by a decrease in COX-2 expression, PGI(2) secretion and H(2)S levels; however, the levels of ROS were not altered. Although the exogenous ROS donor, H(2)O(2), triggered similar degrees of proliferation to CoCl(2), the ROS scavenger, N-acetyl-L-cysteine (NAC), markedly abolished the H(2)O(2)‑induced cell proliferation, as opposed to the CoCl(2)-induced proliferation. The CoCl(2)-induced proliferation of HPASMCs was suppressed by exogenously applied PGI(2). The addition of H(2)S (NaHS) attenuated the CoCl(2)-induced cell proliferation through the increase in the intercellular content of H(2)S. Importantly, the exposure of the cells to H(2)S suppressed the CoCl(2)-induced downregulation in COX-2 expression and PGI(2) secretion from the HPASMCs. In conclusion, the results from the current study suggest that H(2)S enhances hypoxia-induced cell proliferation through the upregulation of COX-2/PGI(2), as opposed to ROS.
AuthorsYunquan Li, Guohui Liu, Dianqi Cai, Baoying Pan, Yuese Lin, Xuandi Li, Shujuan Li, Ling Zhu, Xinxue Liao, Huishen Wang
JournalInternational journal of molecular medicine (Int J Mol Med) Vol. 33 Issue 2 Pg. 359-66 (Feb 2014) ISSN: 1791-244X [Electronic] Greece
PMID24337227 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Reactive Oxygen Species
  • Sulfides
  • Cobalt
  • Hydrogen Peroxide
  • Epoprostenol
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • cobaltous chloride
  • sodium bisulfide
  • Acetylcysteine
  • Hydrogen Sulfide
Topics
  • Acetylcysteine (pharmacology)
  • Cell Hypoxia (drug effects)
  • Cell Line
  • Cell Proliferation (drug effects)
  • Cobalt (pharmacology)
  • Cyclooxygenase 2 (genetics, metabolism)
  • Down-Regulation
  • Epoprostenol (metabolism)
  • Familial Primary Pulmonary Hypertension
  • Humans
  • Hydrogen Peroxide (adverse effects)
  • Hydrogen Sulfide (pharmacology)
  • Hypertension, Pulmonary (drug therapy)
  • Myocytes, Smooth Muscle (cytology, drug effects, metabolism)
  • Oxidative Stress (drug effects)
  • Pulmonary Artery (cytology)
  • Reactive Oxygen Species (metabolism)
  • Sulfides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: